期刊文献+

兽用抗菌药物土拉霉素研究进展 被引量:8

下载PDF
导出
摘要 土拉霉素是兽类专用的新型大环内酯类抗菌素,欧盟和美国已批准将其用于牛和猪呼吸系统疾病的防治。土拉霉素给药后吸收迅速,生物利用度高,半衰期长,药效持久。肠胃外单次给药即能提供全程的治疗,在兽医临床具有广阔的应用前景。综述了土拉霉素的理化性质、作用机理、抗菌活性、药代动力学、临床应用和不良反应,为该药在兽医临床的应用提供资料。
出处 《兽药与饲料添加剂》 2006年第4期4-6,共3页 Veterinary Pharmaceuticals & Feed Additives
  • 相关文献

参考文献9

  • 1Godinho K S,Rae A Nanjiani I A,et al. Efficacy of tulathromycin in the treatment of bovine respiratory disease associated with induced Mycoplasma boris infections in young dairy calves[J]. Vet Ther, 2005,6(2) :96-112.
  • 2Norcia L J L,Silvia A M,Santoro S L,et al. In vitro microbiological characterization of a novel azalide, two triamilides and an azalide ketal against bovine and porcine respiratory pathogens[J]. J Antibiot,2004,57:280-288.
  • 3Hart F J,Kilgore R W,Nutsch R G,et al. Efficacy of tulathromycin in the treatment of respiratory disease in pigs caused by Actinobacillus pleuropneumoniae [ J ]. Vet Rec, 2006,158 ( 13 ) : 433.
  • 4Nutsch R G,Hart F J,Rooney K A ,et al. Efficacy of tulathromycin injectable solution for the treatment of naturally occurring Swine respiratory disease [ J ] .Vet Ther, 2005,6 ( 2 ) : 214-224.
  • 5McKelvie J, organ J H,Nanjiani I A,et al. Evaluation of tulathromycin for the treatment of pneumonia following experimental infection of swine with Mycoplasma hyopneumoniae [J].Vet Ther,2005,6(2) : 197-202.
  • 6Nanjiani I A,McKelvie J,Benchaoui H A,et al. Evaluation of the therapeutic activity of tulathromycin against swine respiratory disease on farms in Europe[J].Vet Ther,200,6(2) :203-213.
  • 7Galer D,Hessong D S, Beato B, et al. An analytical method for the analysis of tulathromycin, an equilibrating tfiamilide, in bovine and porcine plasma and lung [J]. J Agric Food Chem,2004, 52(8) : 2179-2191.
  • 8Nowakowski M A, Inskeep P B, et al. Pharmacokinetics and lung tissue concentrations of tulathromycin, a new triamilide antibiotic,in cattle[J]. Vet Ther, 2004,5( 1 ):60-74.
  • 9Benchaoui H A, Nowakowski M, et al. Pharmacokinetics and lung tissue concentrations of tulathromycin in swine [J]. J Vet Pharmacol Ther, 2004,27(4) :203-210.

同被引文献83

  • 1潘强,陈国琪,赵晓冬,刘彦艳.HPLC法测定注射用阿奇霉素的含量[J].中国药品标准,2004,5(3):57-58. 被引量:5
  • 2李汶.HPLC-ELSD在抗生素药品检验中的应用[J].中国药品标准,2006,7(1):9-11. 被引量:2
  • 3李玮,郭腾,陈洪亮,禚宝山.兽用新型大环内酯类抗生素——土拉霉素(ulathromycin)[J].中国动物保健,2006,8(4):38-39. 被引量:7
  • 4Benchaoui H A, Nowakowski M, Sherington J, et al. Pharmacokinetics and lung tissue concentrations of tulathromycin in swine [J].Veterinary Pharmacol and Therapeutics[J].2004,27(4):203-210.
  • 5FDA. Freedom of Information Summary NADAI41-244[Z]. Date of Approval:December 28,2007.
  • 6Orhan Sahin, Paul J. Plummer, et al. Emergence of a Tetracycline-resistant Campylobacter jejuni Clo Associated with Outbreaks of Ovine Abortion in th United States[J].Journal of clinical Microbiology 2008,46(5):1663-1671.
  • 7Godinho K S. Susceptibility testing of tulathromycin interpretative Breakpoints andsusceptibility of field isolates[J].Veterinary Microbiology. 2008, 129(3-4):426-432.
  • 8Nowakowski, Inskeep, et al. Pharmacokinetics and lung tissue concentrations of tulathromycin, a new triamilide antibiotic, In cattle[J].Veterinary Therapeutics, 2004,5(1):60-74.
  • 9Eberhard Scheuch, Janina Spieker, Monica Venner, et al Quantitative determination of the macrolide antibiotic tulathromycin in plasma and bronchoalveolar cells of foals using tandem mass spectrometry[J]. Journal of Chromatography B, 2007,850:464-470.
  • 10Committee for Veterinary Medicinal Products Tulathromycin, Summary Report(2).European Medicines Agency Veterinary Medicines and Inspections[Z].EMEA/MRL/ 894/04-Final. 2004.

引证文献8

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部